EIR Hercon Pharmaceuticals Nov 2003

David Hafner FDA$595.00 - Available Now

FDA investigators audited the Hercon Pharmaceuticals - Emigsville, PA, United States facility and issued inspectional observation (via FDA 483) on 05 Nov 2003.

Product details

  • Category:
  • Inspection end: 05 Nov 2003
  • Location: Emigsville, United States
  • FEI: 2522638
Add To Cart